Literature DB >> 26217821

Data supporting the design and evaluation of a universal primer pair for pseudogene-free amplification of HPRT1 in real-time PCR.

Reza Valadan1, Akbar Hedayatizadeh-Omran2, Mahdyieh Naghavi Alhosseini-Abyazani2, Omolbanin Amjadi2, Alireza Rafiei1, Mohsen Tehrani1, Reza Alizadeh-Navaei2.   

Abstract

Hypoxanthine-guanine phosphoribosyltransferase 1 (HPRT1) is a common housekeeping gene for sample normalization in the quantitative reverse transcriptase polymerase chain (qRT-PCR). However, co-amplification of HPRT1 pseudogenes may affect accurate results obtained in qRT-PCR. We designed a primer pair (HPSF) for pseudogene-free amplification of HPRT1 in qRT-PCR [1]. We showed specific amplification of HPRT1 mRNA in some common laboratory cell lines, including HeLa, NIH/3T3, CHO, BHK, COS-7 and VERO. This article provides data supporting the presence and location of HPRT1 pseudogenes within human and mouse genome, and the strategies used for designing primers that avoid the co-amplification of contaminating pseudogenes in qRT-PCR. In silico analysis of human genome showed three homologous sequences for HPRT1 on chromosomes 4, 5 and 11. The mRNA sequence of HPRT1 was aligned with the pseudogenes, and the primers were designed toward 5' end of HPRT1 mRNA that was only specific to HPRT1 mRNA not to the pseudogenes. The standard curve plot generated by HPSF primers showed the correlation coefficient of 0.999 and the reaction efficiency of 99.5%. Our findings suggest that HPSF primers can be recommended as a candidate primer pair for accurate and reproducible qRT-PCR assays.

Entities:  

Year:  2015        PMID: 26217821      PMCID: PMC4510554          DOI: 10.1016/j.dib.2015.06.009

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Value of the data HPRT1 is a sensitive internal control for normalization of gene expression in qRT-PCR. HPSF primer pair allows pseudogene-free amplification of HPRT1 mRNA in qRT-PCR. HPSF primer pair provides specific and high efficient amplification of HPRT1 in qRT-PCR. HPSF primer pair amplifies HPRT1 mRNA across a wide range of mammalian species.

Data, experimental design, materials and methods

Primer design

Prior to the identification of human genome sequences, it was shown that HPRT1 contained four pseudogenes on chromosome 3, 5, and 11 [2,3]. Here to identify putative pseudogenes of HPRT1, human and mouse HPRT1 mRNA sequences were used as baits in the Blat and Blast online tools at UCSC Genome Bioinformatics (https://genome.ucsc.edu/) and National Centre for Biotechnology Information (http://www.ncbi.nlm.nih.gov/) respectively. Sequences scored more than 400 and 283 for human and mouse HPRT1 mRNA were selected for further analysis. In consistent with a previous study [4], we also identified three pseudogenes for human HPRT1 on chromosomes 4, 5, and 11 and one for mouse HPRT1 on chromosome 17 (Table 1). To design pseudogene-free primers, HPRT1 mRNA and pseudogene sequences were aligned using CLC Main Workbench software version 5.5 (Qiagen, USA) (see Fig. 1 in Ref. [1]). In order to avoid co-amplification of genomic DAN (gDNA) contamination, unique regions of HPRT1 mRNA that corresponded to exon−exon junctions were selected. In addition, HPRT1 mRNA sequences of human, mouse, rat, Chinese hamster, golden hamster, and rhesus monkey were aligned to design a universal primer pair capable of amplifying HPRT1 mRNA in these species (Fig. 1). Primers were designed using Allele ID primer design software version 7.5 (Premier Biosoft, USA) (Table 2). In silico analysis also demonstrated that HPSF primer pair potentially covers a wide taxonomic range in mammals spanning from whale to human (Table 3).
Table 1

Detail information of HPSF primers.

Primer namePrimer sequences (5′−3′)Length (bp)Tm(°C)GC content (%)Nucleotide position (NM_000194.2)
HPSF -FGGACTAATTATGGACAGGACTG2261.845.5285–306
HPSF -RGCTCTTCAGTCTGATAAAATCTAC246137.50456–479
Fig. 1

Alignment of HPRT1 mRNAs from different species to identify appropriate regions for primer design. High level of sequence similarity between HPRT1 mRNA sequences in different species makes it possible to design a universal cross-species primer. Black boxes show forward and reverse primer binding regions.

Table 2

HPRT1 pseudogenes in human and mouse.

HPRT1pseudogenes (NCBI gene ID)Chromosomal locationIdentity to HPRT1 mRNA (% and positions)
HPRT1P1(ID: 100130067)Chromosome 4, NC_000004.12 (15864937. 15865569 complement)75%
(237–559) (549–1352)
HPRT1P2(ID: 3254)Chromosome 5, NC_000005.10 (30248374. 30249481)77%
(55–669) (836–1413)
HPRT1P3(ID: 3255)Chromosome 11, NC_000011.10 (93990676. 93991522, complement); Chromosome 11, NC_000011.10 (93998649. 93999220, complement)83%
(162–725) (748–1377)
Hprt-ps1(ID: 111269)Mouse Chromosome 17, NC_000083.6 (65396008. 65395223 complement)75%
(526–1272)
Table 3

HPRT1 mRNA sequences can be amplified by HPSF primer in various species.

SpeciesaAccession numberSpeciesbAccession numberSpeciescAccession number
Homo sapiensNM_000194.2Neovison visonJN587807.1Microtus rossiaemeridionalisGU645978.1
Tupaia chinensisXM_006171444.1Mirounga angustirostrisJN820130.1Microtus arvalisGU645977.1
Spermophilus tridecemlineatusXM_005337680.1Loxodonta AfricanaXM_003420864.1Myodes glareolusJN701897.1
Echinops telfairiXM_004715363.1Bos TaurusNM_001034035.2Microtus oeconomusJN701898.1
Jaculus jaculusXM_004653986.1Mustela putoriusfuroXM_004815015.1 XM_004778420.1Cricetulus longicaudatusX59652.1
X17656.1
Tursiops truncatusXM_004323200.1Bos mutusXM_005911180.1Ochotona princepsXM_004582998.1
Orcinus orcaXM_004285480.1Leptonychotes weddelliiXM_006744882.1Microtus ochrogasterXM_005358462.1
XM_006730753.1
Nomascus leucogenysXM_003272534.2 XM_003272533.2Bubalus bubalisXM_006074802.1Cricetulus griseusXM_003503017.1
Gorilla gorilla gorillaXM_004064891.1Panthera tigrisaltaicaXM_007093584.1Mus spretusM20011.1
Saimiri boliviensisboliviensisXM_003931150.1Felis catusXM_006944016.1Mesocricetu sauratusXM_005085546.1
Papio AnubisXM_003918303.1Bubalus bubalisXM_006074802.1Mus musculusNM_013556.2
Pan paniscusXM_003814508.1Panthera tigrisaltaicaXM_007093584.1Rattus norvegicusNM_012583.2
Otolemur garnettiiXM_003796967.1Trichechus manatus latirostrisXM_004379641.1
Pongo abeliiXM_002832128.2Ovis ariesXM_004022693.1
Callithrix jacchusXM_002763292.2Myotis davidiiXM_006759719.1
Macaca mulattaXM_001097691.2Vicugna pacosXM_006215984.1 XM_006201457.1
Elephantulus edwardiiXM_006881880.1Camelus ferusXM_006194437.1
Sus scrofaNM_001032376.2Myotis lucifugusXM_006082071.1
Macaca fascicularisNM_001283594.1Pantholops hodgsoniiXM_005982399.1 XM_005956708.1
Pan troglodytesNM_001110817.1Myotis brandtiiXM_005872845.1
Tursiops truncatusDQ404543.1Capra hircusXM_005700316.1 XM_005698763.1
Stenella coeruleoalbaDQ533610.1Lipotes vexilliferXM_007462883.1
Akodon cursorAF254384.1Balaenoptera acutorostrata scammoniXM_007174545.1
Physeter catodonXM_007117444.1 XM_007101314.1

The HPSF primer set is fully matched with these species.

HPSF forward primer contains a mismatch at position of 21 for these species.

HPSF forward primer contains a mismatch at position of 6 for these species.

Cell lines and cell culture

HeLa, NIH/3T3, CHO, BHK, VERO and COS-7 cell lines were obtained from Pasteur Institute of Iran (Tehran, Iran). The cells were cultured in RPMI 1640 (PAA, Pasching/Austria) containing inactivated fetal bovine serum (PAA, Pasching/ Austria), l-glutamine (300 mg/l), penicillin (100 U/ml) and streptomycin (100 μg/ml). The cell lines were maintained in 5% CO2 at 37 °C in an incubator (Memmert, Germany) with 95% humidity.

Nucleic acid extraction

The cell lines were cultured to Subconfluent stage in 25 cm2 culture flasks (SPL, South Korea) and then genomic DNA and total RNA was extracted using AccuPrep®Genomic DNA Extraction Kit (Bioneer, Korea) and Qiagen RNeasy Mini Kit (Qiagen, Germany), respectively. The quantity and integrity of the isolated nucleic acids were verified by Nano-spectrophotometer (WPA, UK) and electrophoresis in a 2% agarose gel, respectively.

First strand cDNA synthesis and polymerase chain reaction

Complementary DNA (cDNA) was synthesized from 1 microgram of the total RNA in a 20 µl reaction using the Omniscript-RT-Kit (Qiagen, Germany) according to manufacturer’s instruction. PCR reaction was carried out in a total volume of 20 µl containing of 10 mM Tris HCl pH 8.4, 50 mM KCl, 200 nmol each forward and reverse primers, 1.5 mM MgCl2, 250 µM dNTP, 1 U of Taq DNA polymerase (Thermo Scientific, Germeny), 2 µl cDNA and 100 ng DNA as templates. The thermal profile included an initial denaturation at 94 °C for 2 min, followed by 40 cycles of amplification at 94 °C for 30 s, 60 °C for 30 s and 72 °C for 30 s and a final extension step at 72 °C for 5 min. The reactions were cycled in an Eppendorf MasterCycler gradient thermal cycler (Germany). The PCR products were visualized after separation on a 2% agarose gel and staining with ethidium bromide. The results of PCR in the all tested cell lines showed that HPSF primers amplified the expected 195 bp products only when cDNA used as templates (see Fig. 1 in Ref. [1]).

DNA sequencing

The accuracy of the amplification reaction was validated by DNA sequencing of the PCR products. The human and mouse amplicons were excised from a 2% agarose gel, and purified using the QIAquick Gel Extraction Kit (Qiagen, Germany) according to the manufacturer’s instructions. The quantity of the purified plasmid was then measured by spectrophotometer (Biochrom WPA, UK). About 10 ng of each amplicon was ligated into pTG19-T cloning vector (Vivantis, Malaysia) and transformed into chemically competent bacterial cells. Sequencing of the inserts was performed using capillary DNA analyzer (ABI 3730, Applied Biosystems, USA) after sequencing reactions with a Big Dye Terminator V3.1 Cycle Sequencing Kit (Applied Biosystems). The nucleotide sequences of human and mouse HPRT1 mRNA were submitted to the GenBank database under the accession numbers KR817914 and KR817915, respectively.

Real-time PCR

Real-time PCR reactions were performed using 2X Thermo Scientific Maxima SYBR Green/ROX qPCR Master Mix (Fisher Scientific, Germany) and run in an iCycler iQ5 (Bio RAD, USA) instrument. The reaction was carried out in a total volume of 20 µl containing 10 µl of 2X master mix, 200 nmol of each forward and reverse primer, and 2 µl of 10-fold serially diluted of HeLa cDNA or pTG19/HPRT1 plasmid as templates. Cycling condition involved an enzyme activation step at 95 °C for 10 min followed by 40 cycles of 95 °C for 10 s, 60 °C for 15 s, and 72 °C for 15 s. In each cycle, an extra step of 72 °C for 10 s was included to collect fluorescence. At the end of PCR, to evaluate specific amplification of the target genes, melting curves ranging from 60 to 95 °C were also included in each run. The slope, intercept, amplification efficiency, and correlation coefficient (R2) of the primer pair were calculated as described previously [5]. The regression line had the correlation coefficient (R2 value) of 0.999 and the reaction efficiency was calculated 99.5% that confirmed accurate real-time results (Fig. 2A). The melt curve analysis also confirmed the specific amplification of HPRT1 mRNA with no evidence for primer dimer or nonspecific products (Fig. 2B). The importance of pseudogene-free amplification of the housekeeping gene in qRT-PCR has been emphasized for glyceraldehyde-3-phosphate dehydrogenase [6], and the data provided here also indicate that primers should be carefully selected for HPRT1 to ensure accurate transcripts quantification in qRT-PCR.
Fig. 2

Representative amplification plots obtained from a 10-fold serial dilution. The corresponding standard curve showed a slope of line −3.335, efficiency 99.5% and R2 0.999 (A). Melting curves and melting peaks of the serial dilution confirmed a specific amplification (B).

Subject areaBiology
More specific subject areaMolecular biology, Quantitative real time PCR
Type of dataTable, figure
How data was acquiredIn silico analysis of HPRT1 pseudogenes using online bioinformatics tools and CLC Main Workbench software (Qiagen, USA) and Allele ID primer design software version 7.5 (Premier Biosoft, USA).Primer efficiency data acquired by analysis of amplification curve using quantitative real time PCR (iQ5, Biorad,USA)
Data formatRaw, analyzed
Experimental factorsHPRT1 pseudogenes, HPRT1 expression, standard curve, HPRT1 expression in HeLa, NIH/3T3, CHO, BHK, VERO and COS-7
Experimental featuresBioinformatics analysis of human and mouse genome were performed to find HPRT1 pseudogenes. HPRT1-specific primers were designed and tested for pseudogene-free amplification of HPRT1 in different cell lines. The primers specificity and efficiency were also determined in qRT-PCR.
Data source locationSari, Iran
Data accessibilityData is provided with this and the main article [1].
  6 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  Pseudogene-free amplification of HPRT1 in quantitative reverse transcriptase polymerase chain reaction.

Authors:  Reza Valadan; Omolbanin Amjadi; Mohsen Tehrani; Alireza Rafiei; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei
Journal:  Anal Biochem       Date:  2015-06-04       Impact factor: 3.365

3.  Pseudogenes of the human HPRT1 gene.

Authors:  Janice A Nicklas
Journal:  Environ Mol Mutagen       Date:  2006-04       Impact factor: 3.216

4.  Organization of the HPRT gene and related sequences in the human genome.

Authors:  P I Patel; R L Nussbaum; P E gramson; D H Ledbetter; C T Caskey; A C Chinault
Journal:  Somat Cell Mol Genet       Date:  1984-09

5.  RT-PCR for the pseudogene-free amplification of the glyceraldehyde-3-phosphate dehydrogenase gene (gapd).

Authors:  Lucy V Harper; Anthony C Hilton; Alan F Jones
Journal:  Mol Cell Probes       Date:  2003-10       Impact factor: 2.365

6.  Pseudogenes as weaknesses of ACTB (Actb) and GAPDH (Gapdh) used as reference genes in reverse transcription and polymerase chain reactions.

Authors:  Yuan Sun; Yan Li; Dianzhong Luo; D Joshua Liao
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

  6 in total
  7 in total

1.  Identification of qPCR reference genes suitable for normalising gene expression in the developing mouse embryo.

Authors:  John C W Hildyard; Dominic J Wells; Richard J Piercy
Journal:  Wellcome Open Res       Date:  2022-09-21

2.  Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way.

Authors:  Klaus-Dieter Schlüter; Annemarie Wolf; Martin Weber; Rolf Schreckenberg; Rainer Schulz
Journal:  Basic Res Cardiol       Date:  2017-09-14       Impact factor: 17.165

3.  Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  John C W Hildyard; Amber M Finch; Dominic J Wells
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

4.  Effects of activation of the LINE-1 antisense promoter on the growth of cultured cells.

Authors:  Tomoyuki Honda; Yuki Nishikawa; Kensuke Nishimura; Da Teng; Keiko Takemoto; Keiji Ueda
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

5.  Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy.

Authors:  Shigenori Nanno; Takeshi Fukuda; Takuya Noda; Eijiro Uchikura; Yuichiro Awazu; Kenji Imai; Makoto Yamauchi; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Mol Clin Oncol       Date:  2022-08-11

6.  Differential gene expression analysis of common target genes for the detection of SARS-CoV-2 using real time-PCR.

Authors:  Reza Valadan; Soheila Golchin; Reza Alizadeh-Navaei; Mohammadreza Haghshenas; Mehryar Zargari; Tahoora Mousavi; Mohammad Ghamati
Journal:  AMB Express       Date:  2022-09-02       Impact factor: 4.126

7.  Optimization of internal reference genes for qPCR in human pancreatic cancer research.

Authors:  Wan-Li Ge; Guo-Dong Shi; Xu-Min Huang; Qing-Qing Zong; Qun Chen; Ling-Dong Meng; Yi Miao; Jing-Jing Zhang; Kui-Rong Jiang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.